Marketing Expert

Proven leader in Marketing and Market Access, driving brand performance through sharp strategic planning and impactful cross-functional execution

Deep expertise in payer engagement, HTA/AMNOG processes and pricing strategy, securing sustainable market access for both launched and pipeline products

Strong ability to align international and local teams, translating global strategies into locally effective, patientfocused initiatives

Recognized for building effective stakeholder partnerships, enhancing brand visibility, accelerating adoption and delivering measurable business impact

Led the Marketing and Healthcare Solutions team

Developed the operational and tactical annual plan for the brand together with the international team

Engaged and collaborated with regional and local health-policy stakeholders to support patient access

Supported the evolution of brand campaigns together with international marketing

Led the local brand planning process, including analysis of the competitive landscape, input into global brand strategy, functional plans and budget

Led cross-functional teams to implement promotional activities defined in the local country brand plan for key target audiences

Developed and executed external stakeholder engagement plans in coordination with cross-functional teams

Represented local requirements and goals for new indications and study designs of pipeline products in the clients area as an interface in the global Value & Access team

Included the perspective of German payers in the global Value & Access strategy

Participated globally to help shape international strategy and key decisions

Supported the global team by contributing local market access knowledge and strategic insights for the clients pipeline

Prepared and implemented payer advisory boards, real-world evidence studies and HTA engagements (e.g., G-BA early advice)

Pricing and reimbursement responsibilities, including the AMNOG procedure

Pipeline consultation for new products

Project lead for AMNOG procedure and price negotiation for Inflammation

Support and implementation of Real-World Evidence (RWE) and Health Economics & Outcomes Research (HEOR) strategy

Managed AMNOG procedure and price negotiations for all new active substances, including pricing, HTA and value strategies

Led LoE (Level of Evidence) management and strategy

Led tender business and strategy

Developed and elaborated collaboration concepts with service providers and external strategic partnerships

Conducted strategic market analysis and screen relevant developments and system options (e.g., reference price, price moratorium)

Processed and implemented tender business/strategy

Negotiated selective contracts with health insurers and service providers

Developed innovative contract solutions and digital innovations